Bay Street News, February, 2019

Reinforces Ongoing Commitment to Delivering Value to Stockholders LINCOLNSHIRE, Ill., Feb. 07, 2019 (GLOBE NEWSWIRE) — CDW Corporation (NASDAQ:CDW), today […]

NEWTOWN, Pa., Feb. 07, 2019 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]

Fiscal Year 2018 GAAP revenue of $1.145 billion Net income of $4.5 million Adjusted EBITDA of $338.1 million Cash flow […]

Approval Based on Clinical Data from the PREMIER Trial – New Indication Provides Options for Patients with Small or Medium, […]

DAVENPORT, Iowa, Feb. 07, 2019 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NYSE: LEE), a leading provider of high quality, trusted, […]

PARSIPPANY, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) — Ogilvy Health (www.ogilvychww.com), the health practice of Ogilvy, a WPP company (NASDAQ: […]

UTRECHT, Netherlands, Feb. 07, 2019 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length […]

LAUSANNE, Switzerland, Feb. 07, 2019 (GLOBE NEWSWIRE) — AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a […]

Reaffirms 2019 Financial Guidance and Announces Consolidation of Women’s Health and Maternal Health Sales Forces Conference Call Scheduled for 8:00 a.m. […]

Mayfield, a women’s health focused drug development company, intends to seek FDA approval for MAY-44 Dyspareunia treatment drug candidate via […]